Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 11 studies | 26% ± 9% | |
type II pneumocyte | 5 studies | 24% ± 13% | |
epithelial cell | 4 studies | 21% ± 5% | |
hepatocyte | 3 studies | 46% ± 16% |
Insufficient scRNA-seq data for expression of EVA1A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1337.78 | 89 / 89 | 91% | 37.86 | 824 / 901 |
liver | 100% | 3078.19 | 226 / 226 | 89% | 45.13 | 363 / 406 |
skin | 93% | 552.93 | 1686 / 1809 | 92% | 40.68 | 433 / 472 |
pancreas | 100% | 1058.41 | 328 / 328 | 84% | 13.77 | 150 / 178 |
thymus | 97% | 190.73 | 634 / 653 | 80% | 27.12 | 483 / 605 |
lung | 100% | 820.31 | 576 / 578 | 72% | 21.22 | 837 / 1155 |
breast | 68% | 143.00 | 313 / 459 | 62% | 7.00 | 695 / 1118 |
uterus | 78% | 145.39 | 133 / 170 | 43% | 7.61 | 199 / 459 |
ovary | 14% | 13.03 | 26 / 180 | 90% | 17.76 | 388 / 430 |
spleen | 100% | 923.82 | 241 / 241 | 0% | 0 | 0 / 0 |
intestine | 30% | 39.47 | 291 / 966 | 61% | 9.11 | 319 / 527 |
eye | 0% | 0 | 0 / 0 | 84% | 25.18 | 67 / 80 |
bladder | 14% | 25.67 | 3 / 21 | 44% | 9.13 | 224 / 504 |
prostate | 56% | 72.57 | 136 / 245 | 1% | 0.05 | 3 / 502 |
stomach | 8% | 7.10 | 30 / 359 | 48% | 7.75 | 136 / 286 |
esophagus | 7% | 6.34 | 108 / 1445 | 36% | 5.39 | 65 / 183 |
adipose | 40% | 51.20 | 486 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 3.73 | 14 / 45 |
heart | 24% | 27.49 | 207 / 861 | 0% | 0 | 0 / 0 |
brain | 6% | 5.39 | 163 / 2642 | 14% | 1.45 | 98 / 705 |
adrenal gland | 4% | 3.41 | 11 / 258 | 13% | 2.09 | 31 / 230 |
lymph node | 0% | 0 | 0 / 0 | 14% | 1.49 | 4 / 29 |
blood vessel | 4% | 5.64 | 56 / 1335 | 0% | 0 | 0 / 0 |
muscle | 3% | 2.93 | 28 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 2.24 | 14 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0006914 | Biological process | autophagy |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005886 | Cellular component | plasma membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | EVA1A |
Protein name | Protein eva-1 homolog A (Protein FAM176A) (Transmembrane protein 166) Eva-1 homolog A, regulator of programmed cell death |
Synonyms | SP24 TMEM166 FAM176A |
Description | FUNCTION: Acts as a regulator of programmed cell death, mediating both autophagy and apoptosis. . |
Accessions | B8ZZF5 ENST00000233712.5 C9J5M4 C9JX09 ENST00000410010.1 Q9H8M9 ENST00000452003.1 ENST00000410071.5 ENST00000432649.5 ENST00000393913.8 ENST00000410113.5 |